Deutsche Bank’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
Other funds holding IMNM
Deutsche Bank's IMNM Position: Q3 2026 in Review
Deutsche Bank reduced its Immunome (IMNM) stake by 9% in Q3 2026, selling an estimated $249K and leaving 101,550 shares worth $2.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1711.
Deutsche Bank first reported a position in IMNM in Q4 2020 and has held it in 13 quarters since. The position peaked at $2.36M in Q2 2026. 109 funds tracked by Wall St. Rank hold IMNM as of Q3 2026.
- Deutsche Bank held 101,550 shares of Immunome worth $2.18M as of Q3 2026.
- Deutsche Bank sold 10,043 Immunome shares in Q3 2026, an estimated $249K.
- Immunome made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #1711 holding.
- Deutsche Bank first reported a position in Immunome in Q4 2020 and has held it in 13 quarters since.
- Deutsche Bank's Immunome position peaked at $2.36M in Q2 2026.
- 109 funds tracked by Wall St. Rank held Immunome as of Q3 2026.
Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.